Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalya V Guseva

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Immunohorizons|August 12, 2021
HLA Class II Polymorphisms Modulate Gut Microbiota and Experimental Autoimmune Encephalomyelitis PhenotypeShailesh K Shahi, Soham Ali, Camille M Jaime, et al.
Oncotarget|March 3, 2012
Inhibition of p53 expression modifies the specificity of chromatin binding by the androgen receptorNatalya V Guseva, Oskar W Rokhlin, Thomas B Bair, et al.
Cancer Biology & Therapy|November 18, 2006
TSA-induced cell death in prostate cancer cell lines is caspase-2 dependent and involves the PIDDosomeAgshin F Taghiyev, Natalya V Guseva, Rebecca A Glover, et al.
Plos One|July 11, 2013
The Glycophosphatidylinositol Anchor of the MCMV Evasin, m157, Facilitates Optimal Cell Surface Expression and Ly49 Receptor RecognitionLindsey E Carlin, Natalya V Guseva, Michael R Shey, et al.
Cancer Biology & Therapy|June 16, 2004
Multiple effects of N-alpha-tosyl-L-phenylalanyl chloromethyl ketone (TPCK) on apoptotic pathways in human prostatic carcinoma cell linesOskar W Rokhlin, Natalya V Guseva, Agshin F Taghiyev, et al.
Cancer Biology & Therapy|April 23, 2005
Trichostatin A (TSA) sensitizes the human prostatic cancer cell line DU145 to death receptor ligands treatmentAgshin F Taghiyev, Natalya V Guseva, Mary T Sturm, et al.
The Prostate|May 7, 2002
Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaPOskar W Rokhlin, Natalya V Guseva, Agshin F Tagiyev, et al.
Molecular Cancer Research : MCR|October 23, 2004
Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell linesNatalya V Guseva, Agshin F Taghiyev, Mary T Sturm, et al.
Cancer Biology & Therapy|December 22, 2009
KN-93 inhibits androgen receptor activity and induces cell death irrespective of p53 and Akt status in prostate cancerOskar W Rokhlin, Natalya V Guseva, Agshin F Taghiyev, et al.
Molecular Cancer Research : MCR|May 20, 2003
Overexpression of BAD potentiates sensitivity to tumor necrosis factor-related apoptosis-inducing ligand treatment in the prostatic carcinoma cell line LNCaPAgshin F Taghiyev, Natalya V Guseva, Hisashi Harada, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Immunohorizons|August 12, 2021
HLA Class II Polymorphisms Modulate Gut Microbiota and Experimental Autoimmune Encephalomyelitis PhenotypeShailesh K Shahi, Soham Ali, Camille M Jaime, et al.
Oncotarget|March 3, 2012
Inhibition of p53 expression modifies the specificity of chromatin binding by the androgen receptorNatalya V Guseva, Oskar W Rokhlin, Thomas B Bair, et al.
Cancer Biology & Therapy|November 18, 2006
TSA-induced cell death in prostate cancer cell lines is caspase-2 dependent and involves the PIDDosomeAgshin F Taghiyev, Natalya V Guseva, Rebecca A Glover, et al.
Plos One|July 11, 2013
The Glycophosphatidylinositol Anchor of the MCMV Evasin, m157, Facilitates Optimal Cell Surface Expression and Ly49 Receptor RecognitionLindsey E Carlin, Natalya V Guseva, Michael R Shey, et al.
Cancer Biology & Therapy|June 16, 2004
Multiple effects of N-alpha-tosyl-L-phenylalanyl chloromethyl ketone (TPCK) on apoptotic pathways in human prostatic carcinoma cell linesOskar W Rokhlin, Natalya V Guseva, Agshin F Taghiyev, et al.
Cancer Biology & Therapy|April 23, 2005
Trichostatin A (TSA) sensitizes the human prostatic cancer cell line DU145 to death receptor ligands treatmentAgshin F Taghiyev, Natalya V Guseva, Mary T Sturm, et al.
The Prostate|May 7, 2002
Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaPOskar W Rokhlin, Natalya V Guseva, Agshin F Tagiyev, et al.
Molecular Cancer Research : MCR|October 23, 2004
Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell linesNatalya V Guseva, Agshin F Taghiyev, Mary T Sturm, et al.
Cancer Biology & Therapy|December 22, 2009
KN-93 inhibits androgen receptor activity and induces cell death irrespective of p53 and Akt status in prostate cancerOskar W Rokhlin, Natalya V Guseva, Agshin F Taghiyev, et al.
Molecular Cancer Research : MCR|May 20, 2003
Overexpression of BAD potentiates sensitivity to tumor necrosis factor-related apoptosis-inducing ligand treatment in the prostatic carcinoma cell line LNCaPAgshin F Taghiyev, Natalya V Guseva, Hisashi Harada, et al.
Pageof 3